<https://rdf.molmedb.upol.cz/reference/ref973> <http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target63>,
		<https://rdf.molmedb.upol.cz/transporter/target62>,
		<https://rdf.molmedb.upol.cz/transporter/target64>,
		<https://identifiers.org/molmedb/MM467518>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2015.09.005"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/bibliographicCitation> "Suzuki S, Kuroda T, Kimoto H, Domon Y, Kubota K, Kitano Y, Yokoyama T, Shimizugawa A, Sugita R, Koishi R, Asano D, Tamaki K, Shinozuka T, Kobayashi H.: Discovery of (phenoxy-2-hydroxypropyl)piperidines as a novel class of voltage-gated sodium channel 1.7 inhibitors. Bioorg Med Chem Lett, Volume 25 (22), 2015"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/pmid> "26358159"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/transporter/tra58131> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref973> .
<https://rdf.molmedb.upol.cz/transporter/tra58127> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref973> .
<https://rdf.molmedb.upol.cz/transporter/tra58123> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref973> .
